US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 12, 2018 (8 years ago)

EPINEPHrine

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Potential leakage of bags.

What was recalled

EPINEPHrine (USP) 4 mg, 5% Dextrose For Inj. (USP) 250 mL Volume: 254 mL single dose bag. For: Peninsular Regional Medical Center. By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-855-25.

Recalling firm
Avella of Deer Valley, Inc. Store 38
NDC code
15082-855-25
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0931-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Epinephrine recalls

See all
Class III · Low risk Ongoing

Epinephrine Injection

Reason Failed Impurities/Degradations Specifications

Fresenius Kabi USA, LLC NDC 63323-696-02 D-0581-2026
Class II · Moderate risk Ongoing

EPINEPHRINE Injection

Reason Lack of Assurance of Sterility

International Medication Systems Ltd. NDC 76329-3318-1 D-0483-2026
Class II · Moderate risk Ongoing

norepinephrine Bitartrate

Reason Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services NDC 71266-5027-02 D-0439-2026
Class II · Moderate risk Ongoing

norepinephrine Bitartrate

Reason Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services NDC 71266-5026-02 D-0438-2026
Class II · Moderate risk Ongoing

Maximum

Reason Stability Data Does Not Support Expiry Date.

HTO Nevada Inc. dba Kirkman D-0387-2026